WRAL

GSK To Utilize RFID Technology To Combat Drug Counterfeiting, Diversion

is using emerging radio frequency identification (RFID) technology as part of a pilot program to crack down on drug counterfeiting and to protect consumers. GSK said Wednesday that bottles of its HIV ...
TipRanks on MSN

GSK’s Blujepa Approved by FDA as New Oral Treatment for Gonorrhoea

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...
Becker's Hospital Review

GSK pays $70M in partnership with Tempus

Pharmaceutical company GSK has paid $70 million to partner with precision medicine company Tempus. Through the partnership, GSK will have access to Tempus’ artificial intelligence platform and ...
Seeking Alpha

Moderna: Assessing The Impact Of GSK's Patent Lawsuit

GSK's lawsuit against Moderna over lipid nanoparticle technology could severely impact Moderna's revenue from Spikevax and mResvia, and delay their breakeven point. The lawsuit adds uncertainty to ...
Becker's Hospital Review

GSK signs partnership with AI company to supercharge drug development

GlaxoSmithKline has signed a multiyear partnership agreement with artificial intelligence-powered pathology company PathAI, according to an April 5 news release. The partnership will focus on ...
TipRanks on MSN

GSK’s Nucala receives positive CHMP opinion for COPD treatment

GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...
WRAL

AskBio Licenses GSK Technology To Attack Muscular Dystrophy, Hemophilia B

, or AskBio, has licensed technology from GlaxoSmithKline that could prove useful in development treatments for muscular dystrophy (MD) and hemophilia B. Other WRAL Top Stories Financial terms were ...
Nature

Partnering with GSK to accelerate vaccine R&D

Combining the science of the immune system and human genetics with advanced technologies is the cornerstone of R&D at GSK, underpinning a pipeline of 57 medicines and vaccines centred on infectious ...
Reuters

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Settlement reached over mRNA-based COVID vaccines CureVac and GSK get $740 million upfront, and royalties BioNTech's deal to buy CureVac on track GSK's own lawsuits against Pfizer, BioNTech unaffected ...
Nasdaq

Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders

Ligand Group is eligible to receive an upfront payment of $7 million and potential milestone payments and fees of up to $154.5 million and tiered royalties SAN DIEGO--(BUSINESS WIRE)-- Ligand ...
MobiHealthNews

GSK adds Chief Digital and Technology Officer and more digital health hires

GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital ...